Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tabernero

Showing results (91-100 of 1,741) with videos related to

Pageof 175
Sort By:
Seminars in Oncology|November 29, 2015
Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid TumorsCinta Hierro, Jordi Rodon, Josep Tabernero
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2014
Paracrine network: another step in the complexity of resistance to EGFR blockade?Ramon Salazar, Gabriel Capellà, Josep Tabernero
The Oncologist|February 29, 2008
Administration of cetuximab every 2 weeks in the treatment of metastatic colorectal cancer: an effective, more convenient alternative to weekly administration?Josep Tabernero, Per Pfeiffer, Andrés Cervantes
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1971
Anti-inflammatory properties of alkyl-pseudothioureas with antibacterial and antifungal activityN Ercoli, J Arbona, E Tabernero
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patientsRodrigo Dienstmann, Ramon Salazar, Josep Tabernero
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Overcoming Resistance to Anti-EGFR Therapy in Colorectal CancerRodrigo Dienstmann, Ramon Salazar, Josep Tabernero
Oncology (Williston Park, N.Y.)|March 19, 2015
Genomic testing in colorectal cancer: how much is enough?Rodrigo Dienstmann, Ramon Salazar, Josep Tabernero
Chemotherapy|January 1, 1974
Therapeutic action of antimicrobial agents in localized infections of miceE Tabernero, E Guaithero, N Ercoli
Current Clinical Pharmacology|March 22, 2012
Application of monoclonal antibodies as cancer therapy in solid tumorsRodrigo Dienstmann, Ben Markman, Josep Tabernero
Optometry and Vision Science : Official Publication of the American Academy of Optometry|April 5, 2011
Visual acuity with simulated and real astigmatic defocusArne Ohlendorf, Juan Tabernero, Frank Schaeffel
Pageof 175

Showing results (91-100 of 1,741) with videos related to

Sort By:
Pageof 175
Seminars in Oncology|November 29, 2015
Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid TumorsCinta Hierro, Jordi Rodon, Josep Tabernero
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2014
Paracrine network: another step in the complexity of resistance to EGFR blockade?Ramon Salazar, Gabriel Capellà, Josep Tabernero
The Oncologist|February 29, 2008
Administration of cetuximab every 2 weeks in the treatment of metastatic colorectal cancer: an effective, more convenient alternative to weekly administration?Josep Tabernero, Per Pfeiffer, Andrés Cervantes
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1971
Anti-inflammatory properties of alkyl-pseudothioureas with antibacterial and antifungal activityN Ercoli, J Arbona, E Tabernero
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patientsRodrigo Dienstmann, Ramon Salazar, Josep Tabernero
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Overcoming Resistance to Anti-EGFR Therapy in Colorectal CancerRodrigo Dienstmann, Ramon Salazar, Josep Tabernero
Oncology (Williston Park, N.Y.)|March 19, 2015
Genomic testing in colorectal cancer: how much is enough?Rodrigo Dienstmann, Ramon Salazar, Josep Tabernero
Chemotherapy|January 1, 1974
Therapeutic action of antimicrobial agents in localized infections of miceE Tabernero, E Guaithero, N Ercoli
Current Clinical Pharmacology|March 22, 2012
Application of monoclonal antibodies as cancer therapy in solid tumorsRodrigo Dienstmann, Ben Markman, Josep Tabernero
Optometry and Vision Science : Official Publication of the American Academy of Optometry|April 5, 2011
Visual acuity with simulated and real astigmatic defocusArne Ohlendorf, Juan Tabernero, Frank Schaeffel
Pageof 175